NCT06786884

Brief Summary

This study is being done to test if paraffin wax can be used to improve the range of motion and function for scars across joints when used in combination with scar rehabilitation therapy sessions. For those randomized to receive it, the paraffin wax will be used alongside the participants' exercise therapy treatments. Currently, treatments that are used in addition to rehabilitation therapy for increasing range of motion across joints in the burn population are limited. By getting more information about how paraffin wax may or may not work, patients in the future that have scars may be able to be helped.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
9mo left

Started Jan 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress64%
Jan 2025Feb 2027

First Submitted

Initial submission to the registry

January 6, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

January 6, 2025

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 22, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Expected
Last Updated

June 13, 2025

Status Verified

June 1, 2025

Enrollment Period

1.1 years

First QC Date

January 6, 2025

Last Update Submit

June 10, 2025

Conditions

Keywords

paraffin waxburn scarscarburnrange of motion

Outcome Measures

Primary Outcomes (1)

  • Range of motion

    Range of motion (degrees) of the affected joint before and after paraffin wax between the paraffin and no paraffin groups

    4th exercise session, an average of 4 weeks post enrollment

Secondary Outcomes (9)

  • Trans-epidermal water loss

    4th exercise session, an average of 4 weeks post enrollment

  • Stiffness

    4th exercise session, an average of 4 weeks post enrollment

  • Pain visual analog scale

    4th exercise session, an average of 4 weeks post enrollment

  • Itch visual analog scale

    4th exercise session, an average of 4 weeks post enrollment

  • Scar surface temperature

    4th exercise session, an average of 4 weeks post enrollment

  • +4 more secondary outcomes

Study Arms (2)

Exercise Therapy Only

OTHER
Device: standard of care exercise therapy

Exercise Therapy with Paraffin Wax Treatment

EXPERIMENTAL
Device: paraffin waxDevice: standard of care exercise therapy

Interventions

This is the treatment group that will receive exercise and paraffin wax

Exercise Therapy with Paraffin Wax Treatment

This is the group that will only receive exercise therapy and no paraffin wax.

Exercise Therapy OnlyExercise Therapy with Paraffin Wax Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Patients with burn scar that crosses an upper or lower extremity joint (shoulder, elbow, wrist, hand, hip, knee, ankle)
  • Patients that have been prescribed a rehabilitation program where paraffin wax could be used as an adjunct to rehab exercise therapy

You may not qualify if:

  • Adults unable to provide informed consent
  • Injury etiology other than burn (ex: cutaneous trauma, cold injury, etc.)
  • Pregnant women
  • Prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

MedStar Washington Hosptial Center

Washington D.C., District of Columbia, 20010, United States

RECRUITING

MeSH Terms

Conditions

BurnsCicatrix

Condition Hierarchy (Ancestors)

Wounds and InjuriesFibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Scientist, Assistant Professor, Principal Investigator

Study Record Dates

First Submitted

January 6, 2025

First Posted

January 22, 2025

Study Start

January 6, 2025

Primary Completion

February 1, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

June 13, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations